Brian C. Evanko - 03 Oct 2025 Form 4 Insider Report for Cigna Group (CI)

Role
President and Chief Operating Officer
Signature
Tyler Gratton, attorney-in-fact
Issuer symbol
CI
Transactions as of
03 Oct 2025
Net transactions value
-$737,630
Form type
4
Filing time
07 Oct 2025, 17:22:53 UTC
Previous filing
28 May 2025
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Evanko Brian C President and Chief Operating Officer 900 COTTAGE GROVE ROAD, BLOOMFIELD Tyler Gratton, attorney-in-fact 07 Oct 2025 0001722909

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Options Exercise $747,333 +5,368 +10% $139.22 56,550 03 Oct 2025 Direct F1
transaction CI Common Stock, $.01 Par Value Sale $1,610,400 -5,368 -9.5% $300.00 51,182 03 Oct 2025 Direct F1
transaction CI Common Stock, $.01 Par Value Options Exercise $125,437 +901 +1.8% $139.22 52,083 06 Oct 2025 Direct F1
holding CI Common Stock, $.01 Par Value 904 03 Oct 2025 By 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Options Exercise $0 -5,368 -86% $0.000000 901 03 Oct 2025 Common Stock, $0.01 Par Value 5,368 $139.22 Direct F1, F3
transaction CI Employee Stock Option (Right to Buy) Options Exercise $0 -901 -100% $0.000000 0 06 Oct 2025 Common Stock, $0.01 Par Value 901 $139.22 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2025.
F2 Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
F3 This option was granted on March 1, 2016. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

Remarks:

President and Chief Operating Officer